子宫动脉血流参数联合血清PLGF、sUAR对子痫前期的诊断效能分析
张燕 , 邹海枫 , 妥英梅
中国现代医学杂志 ›› 2026, Vol. 36 ›› Issue (17) : 103 -108.
子宫动脉血流参数联合血清PLGF、sUAR对子痫前期的诊断效能分析
Analysis of the diagnostic efficacy of uterine artery doppler parameters combined with serum PLGF and sUAR ratio for preeclampsia
目的 探究子宫动脉血流参数联合血清胎盘生长因子(PLGF)、血清尿酸/白蛋白比值(sUAR)对子痫前期(PE)的诊断效能。 方法 选取2024年5月—2025年7月在昌吉回族自治州人民医院产检的80例PE患者作为PE组,另选取同期50例正常妊娠者作为对照组。所有研究对象均行子宫动脉多普勒超声检查,并检测血清PLGF及sUAR。采用多因素一般Logistic回归模型分析PE的影响因素并构建列线图。绘制受试者工作特征(ROC)曲线分析子宫动脉血流参数联合血清PLGF、sUAR对PE的诊断效能。 结果 PE组的搏动指数(PI)、阻力指数(RI)、收缩期峰值流速/舒张末期流速比值(S/D)均高于对照组(P <0.05)。PE组的血清PLGF水平低于对照组,sUAR水平高于对照组(P <0.05)。多因素一般Logistic回归分析结果表明,PI高[O^R =2.950(95% CI:1.122,7.814)]、RI高[O^R =2.333(95% CI:1.065,5.133)]、S/D高[O^R =4.628(95% CI:1.912,11.199)]、PLGF低[O^R =0.201(95% CI:0.011,0.444)]、sUAR高[O^R =4.122(95% CI:1.599,11.02)]均为发生PE的危险因素(P <0.05)。ROC曲线分析结果显示,子宫动脉血流参数联合血清PLGF、sUAR的联合模型诊断PE的曲线下面积为0.976(95% CI:0.955,1.000),敏感性为95.6%(95% CI:0.916,0.979),特异性为94.6%(95% CI:0.835,0.989)。 结论 子宫动脉血流参数联合血清PLGF、sUAR对PE具有较高的诊断效能。
Objective To investigate the diagnostic efficacy of uterine artery hemodynamics combined with serum placental growth factor (PLGF) and uric acid/albumin ratio (sUAR) in pregnant women with preeclampsia (PE). Methods A total of 80 PE patients treated at Changji Hui Autonomous Prefecture People's Hospital from May 2024 to July 2025 were selected as the PE group, and 50 women with normal pregnancies during the same period were selected as the control group. All subjects underwent uterine artery hemodynamic examinations and serum PLGF and sUAR level measurements. Logistic regression analysis was used to identify influencing factors for PE and to construct a nomogram. Receiver operating characteristic (ROC) curves were plotted to analyze the diagnostic efficacy of uterine artery hemodynamics combined with serum PLGF and sUAR levels for PE. Results The pulsatility index (PI), resistance index (RI), and systolic/diastolic velocity ratio (S/D) in the PE group were significantly higher than those in the control group (P < 0.05). Serum PLGF levels were lower, and sUAR levels were higher in the PE group compared to the control group (P < 0.05). Logistic regression analysis, with PE as the dependent variable, showed that elevated PI [O^R = 2.950 (95% CI: 1.122, 7.814) ], elevated RI [O^R = 2.333 (95% CI: 1.065, 5.133) ], elevated S/D [O^R = 4.628 (95% CI: 1.912, 11.199) ], decreased PLGF [O^R = 0.201 (95% CI: 0.011, 0.444) ], and elevated sUAR level [O^R = 4.122 (95% CI: 1.599, 11.02) ] were all risk factors for developing PE (P < 0.05). The ROC curve demonstrated that the combination of uterine artery hemodynamic parameters with serum PLGF and sUAR levels achieved an AUC value of 0.976, with a sensitivity of 95.6% (95% CI: 0.916, 0.979) and a specificity of 94.6% (95% CI: 0.835, 0.989). Conclusion The combination of uterine artery hemodynamics with serum PLGF and sUAR demonstrates significant diagnostic value for preeclampsia in pregnant women.
| [1] |
Roberts J M. Preeclampsia epidemiology(ies) and pathophysiology(ies)[J]. Best Pract Res Clin Obstet Gynaecol, 2024, 94: 102480. |
| [2] |
Chang K J, Seow K M, Chen K H. Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition[J]. Int J Environ Res Public Health, 2023, 20(4): 2994. |
| [3] |
姜克萍, 彭丽, 杨静, 外周血miR-let-7a联合子宫动脉血流动力学指标对重度子痫前期患者妊娠结局的影响[J]. 中国妇产科临床杂志, 2025, 26(1): 55-58. |
| [4] |
谷孝月, 刘志明, 赵会新, 重度子痫前期患者孕期子宫动脉血流动力学指标与产后胎盘组织中PARP-1和TNF-α表达的相关性研究[J]. 中国妇幼健康研究, 2025, 36(2): 63-69. |
| [5] |
熊俊, 胡伟, 李惠兰, 基于三维能量多普勒超声联合PLGF的子痫前期风险预测模型的建立[J]. 中国计划生育和妇产科, 2023, 15(6): 42-47. |
| [6] |
周永红, 魏丹, 郭瑜, 血清尿酸/白蛋白比值、乳酸脱氢酶及碱性磷酸酶测定对重度子痫前期的辅助诊断价值研究[J]. 中国医药导报, 2025, 22(1): 26-30. |
| [7] |
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4): 227-238. |
| [8] |
Bokuda K, Ichihara A. Preeclampsia up to date-what's going on?[J]. Hypertens Res, 2023, 46(8): 1900-1907. |
| [9] |
Bisson C, Dautel S, Patel E, et al. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum[J]. Front Med (Lausanne), 2023, 10: 1144170. |
| [10] |
陈钰, 李京阳, 李力, 内分泌因素调控子痫前期发病的研究进展[J]. 中华妇产科杂志, 2025, 60(7): 571-573. |
| [11] |
霍晓燕, 薛洁, 张利玲, 子痫前期孕妇血清sFlt-1、FGF-19水平与妊娠结局的关系研究[J]. 中国现代医学杂志, 2025, 35(13): 6-11. |
| [12] |
罗福梅, 雷阿明, 史艳飞, 子宫动脉血流动力学联合血清PLGF、CA125对子痫前期的预测价值[J]. 河北医药, 2025, 47(4): 551-554. |
| [13] |
郑路路, 杨丽萍, 马建彩, 小剂量阿司匹林联合低分子肝素钙对早发型PE患者子宫动脉血流、脂代谢、凝血功能及妊娠结局影响[J]. 中国计划生育学杂志, 2023, 31(11): 2615-2620. |
| [14] |
赵鑫鑫, 朱春玉. 妊娠期孕妇血清TTR、PLGF水平变化及用于诊断子痫前期的价值[J]. 中国妇产科临床杂志, 2025, 26(3): 255-256. |
| [15] |
韩肖燕, 杨桦. 妊娠中期血清PLGF对子痫前期患者的影响及其预测价值[J]. 中国综合临床, 2025, 41(4): 248-252. |
| [16] |
高海侠, 张晓月. 孕晚期超声S/D值联合尿酸水平预测子痫前期并发胎儿生长受限不良妊娠结局的临床价值[J]. 中国医学计算机成像杂志, 2024, 30(5): 599-603. |
| [17] |
史峻梅, 李凤秋, 杨孜, 缺血修饰白蛋白在子痫前期重症发展中的临床预警价值初探[J]. 中华妇产科杂志, 2024, 59(8): 583-590. |
| [18] |
Santulli G, Kansakar U, Varzideh F. Epidemiology and pathophysiology of preeclampsia: new mechanistic insights[J]. Hypertension, 2025, 82(5): 800-803. |
| [19] |
Sugulle M, Fiskå B S, Jacobsen D P, et al. Placental senescence and the two-stage model of preeclampsia[J]. Am J Reprod Immunol, 2024, 92(1): e13904. |
| [20] |
韩钰静, 王晶, 任景珊, 血清sFlt-1、PLGF与子痫前期发病及病情严重程度的关系[J]. 临床和实验医学杂志, 2024, 23(7): 738-741. |
| [21] |
胡群, 华静, 许燕姗, 子痫前期患者血清FGF-21水平、sFlt-1/PlGF比值及对妊娠结局的预测价值[J]. 检验医学与临床, 2026, 23(7): 971-975. |
| [22] |
张青青, 闻明, 陈琦. 超声心动图评估心外膜脂肪层厚度对子痫前期的预测价值[J]. 实用妇产科杂志, 2025, 41(3): 242-245. |
| [23] |
廉佳丽, 王艳, 贾跃旗. 血清sFlt-1、PLGF、sFlt-1/PLGF以及PAPP-A水平与孕妇子痫前期发病及病情严重程度的关系研究[J]. 内蒙古医科大学学报, 2025, 47(1): 63-66. |
| [24] |
张丽霞, 申井利, 刘世国, 血清尿酸和白蛋白检测在子痫前期诊断中的应用[J]. 中国妇幼保健, 2022, 37(14): 2633-2636. |
| [25] |
闫坤, 陆进, 周健红, 子痫前期孕妇血清尿酸影响因素的预测模型构建与验证[J]. 医学研究杂志, 2025, 54(9): 98-102. |
新疆维吾尔自治区自然科学基金(2025D01C382)
昌吉州科技计划项目(2023S04-03)
/
| 〈 |
|
〉 |